cetylpyridinium has been researched along with Buruli Ulcer in 1 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
Buruli Ulcer: A lesion in the skin and subcutaneous tissues due to infections by MYCOBACTERIUM ULCERANS. It was first reported in Uganda, Africa.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Owusu, E | 1 |
| Newman, MJ | 1 |
| Akumwena, A | 1 |
| Bannerman, E | 1 |
| Pluschke, G | 1 |
1 other study available for cetylpyridinium and Buruli Ulcer
| Article | Year |
|---|---|
Evaluating decontamination protocols for the isolation of Mycobacterium ulcerans from swabs.
Topics: Anti-Infective Agents; Bacteriological Techniques; Buruli Ulcer; Cetylpyridinium; Decontamination; G | 2017 |